BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kozela E, Krawczyk M, Kos T, Juknat A, Vogel Z, Popik P. Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats. Mol Neurobiol 2020;57:1733-47. [PMID: 31823199 DOI: 10.1007/s12035-019-01831-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Matheson J, Bourgault Z, Le Foll B. Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review. Biomolecules 2022;12:1462. [DOI: 10.3390/biom12101462] [Reference Citation Analysis]
2 Suárez Santiago JE, Roldán GR, Picazo O. Ketamine as a pharmacological tool for the preclinical study of memory deficit in schizophrenia. Behav Pharmacol 2022. [PMID: 36094064 DOI: 10.1097/FBP.0000000000000689] [Reference Citation Analysis]
3 Białoń M, Wąsik A. Advantages and Limitations of Animal Schizophrenia Models. Int J Mol Sci 2022;23:5968. [PMID: 35682647 DOI: 10.3390/ijms23115968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li XJ, Yu JH, Wu X, Zhu XM, Lv P, Du Z, Lu Y, Wu X, Yao J. Ketamine enhances dopamine D1 receptor expression by modulating microRNAs in a ketamine-induced schizophrenia-like mouse model. Neurotoxicol Teratol 2022;:107079. [PMID: 35202796 DOI: 10.1016/j.ntt.2022.107079] [Reference Citation Analysis]
5 Jenkins BW, Buckhalter S, Perreault ML, Khokhar JY. Cannabis Vapor Exposure Alters Neural Circuit Oscillatory Activity in a Neurodevelopmental Model of Schizophrenia: Exploring the Differential Impact of Cannabis Constituents. Schizophrenia Bulletin Open 2022;3. [DOI: 10.1093/schizbullopen/sgab052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Poulia N, Delis F, Brakatselos C, Ntoulas G, Asprogerakas MZ, Antoniou K. CBD Effects on Motor Profile and Neurobiological Indices Related to Glutamatergic Function Induced by Repeated Ketamine Pre-Administration. Front Pharmacol 2021;12:746935. [PMID: 34776964 DOI: 10.3389/fphar.2021.746935] [Reference Citation Analysis]
7 Wang CM, Chen WC, Zhang Y, Lin S, He HF. Update on the Mechanism and Treatment of Sevoflurane-Induced Postoperative Cognitive Dysfunction. Front Aging Neurosci 2021;13:702231. [PMID: 34305576 DOI: 10.3389/fnagi.2021.702231] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
8 Hoffman KL. From the Clinic to the Laboratory, and Back Again: Investigations on Cannabinoids and Endocannabinoid System Modulators for Treating Schizophrenia. Front Psychiatry 2021;12:682611. [PMID: 34290632 DOI: 10.3389/fpsyt.2021.682611] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Dorofeikova MV, Kutcher EO, Petrova NN, Egorov AY. Experimental Models of Cognitive Impairments in Schizophrenia. Neurosci Behav Physi 2021;51:765-773. [DOI: 10.1007/s11055-021-01133-y] [Reference Citation Analysis]
10 Sartim AG, Marques J, Silveira KM, Gobira PH, Guimarães FS, Wegener G, Joca SR. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects. Neuropharmacology 2021;195:108679. [PMID: 34157363 DOI: 10.1016/j.neuropharm.2021.108679] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Pedrazzi JFC, Sales AJ, Guimarães FS, Joca SRL, Crippa JAS, Del Bel E. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum. Prog Neuropsychopharmacol Biol Psychiatry 2021;111:110352. [PMID: 34015384 DOI: 10.1016/j.pnpbp.2021.110352] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
12 Jenkins BW, Buckhalter S, Perreault ML, Khokhar JY. Cannabis Vapour Exposure Alters Neural Circuit Oscillatory Activity In A Neurodevelopmental Model Of Schizophrenia: Exploring The Differential Impact Of Cannabis Constituents.. [DOI: 10.1101/2021.04.28.441799] [Reference Citation Analysis]
13 Scarante FF, Ribeiro MA, Almeida-Santos AF, Guimarães FS, Campos AC. Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders. Front Pharmacol 2020;11:618065. [PMID: 33613284 DOI: 10.3389/fphar.2020.618065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
14 Brakatselos C, Delis F, Asprogerakas MZ, Lekkas P, Tseti I, Tzimas PS, Petrakis EA, Halabalaki M, Skaltsounis LA, Antoniou K. Cannabidiol Modulates the Motor Profile and NMDA Receptor-related Alterations Induced by Ketamine. Neuroscience 2021;454:105-15. [PMID: 32950556 DOI: 10.1016/j.neuroscience.2020.09.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Kennedy EKC, Perono GA, Nemez DB, Holloway AC, Thomas PJ, Letcher R, Marvin C, Stetefeld J, Stout J, Peters O, Palace V, Tomy G. Increasing cannabis use and importance as an environmental contaminant mixture and associated risks to exposed biota: A review. Critical Reviews in Environmental Science and Technology 2022;52:203-39. [DOI: 10.1080/10643389.2020.1819730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]